Global Adeno-Associated Virus (AAV) Gene Therapy Supply, Demand and Key Producers, 2023-2029

Global Adeno-Associated Virus (AAV) Gene Therapy Supply, Demand and Key Producers, 2023-2029

Page: 123

Published Date: 08 Jun 2023

Category: Service & Software

PDF Download

Get FREE Sample

Customize Request

  • sp_icon1 sp_icon1_b Description
  • sp_icon2 sp_icon2_b Table of Contents
  • sp_icon3 sp_icon3_b Table of Figures
  • sp_icon4 sp_icon4_b Research Methodology
  • sp_icon1 sp_icon1_b Companies Mentioned
  • sp_icon1 sp_icon1_b Related Reports
  • sp_icon1 sp_icon1_b Product Tags
btl

Description

The global Adeno-Associated Virus (AAV) Gene Therapy market size is expected to reach $ 2966.6 million by 2029, rising at a market growth of 8.4% CAGR during the forecast period (2023-2029).

This report studies the global Adeno-Associated Virus (AAV) Gene Therapy demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for Adeno-Associated Virus (AAV) Gene Therapy, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Adeno-Associated Virus (AAV) Gene Therapy that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Adeno-Associated Virus (AAV) Gene Therapy total market, 2018-2029, (USD Million)
Global Adeno-Associated Virus (AAV) Gene Therapy total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Adeno-Associated Virus (AAV) Gene Therapy total market, key domestic companies and share, (USD Million)
Global Adeno-Associated Virus (AAV) Gene Therapy revenue by player and market share 2018-2023, (USD Million)
Global Adeno-Associated Virus (AAV) Gene Therapy total market by Type, CAGR, 2018-2029, (USD Million)
Global Adeno-Associated Virus (AAV) Gene Therapy total market by Application, CAGR, 2018-2029, (USD Million)
This reports profiles major players in the global Adeno-Associated Virus (AAV) Gene Therapy market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Creative Biolabs, Affinia Therapeutics, Spark Therapeutics, AGC Biologics, StrideBio, SIRION Biotech, Neurophth Biotechnology, Belief BioMed and BiBo Biopharma Engineering Co., LTD., etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Adeno-Associated Virus (AAV) Gene Therapy market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global Adeno-Associated Virus (AAV) Gene Therapy Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World

Global Adeno-Associated Virus (AAV) Gene Therapy Market, Segmentation by Type
Luxturna
Zolgensma
Others

Global Adeno-Associated Virus (AAV) Gene Therapy Market, Segmentation by Application
Central Nervous System Diseases
Ocular Diseases
Liver-directed Diseases
Other Hereditary Diseases

Companies Profiled:
Creative Biolabs
Affinia Therapeutics
Spark Therapeutics
AGC Biologics
StrideBio
SIRION Biotech
Neurophth Biotechnology
Belief BioMed
BiBo Biopharma Engineering Co., LTD.
Beihai Kangcheng
PackGene Biotech
Sarepta Therapeutics
Carbon BioSciences
Kelonia Therapeutics
Roche
Remedium Bio

Key Questions Answered
1. How big is the global Adeno-Associated Virus (AAV) Gene Therapy market?
2. What is the demand of the global Adeno-Associated Virus (AAV) Gene Therapy market?
3. What is the year over year growth of the global Adeno-Associated Virus (AAV) Gene Therapy market?
4. What is the total value of the global Adeno-Associated Virus (AAV) Gene Therapy market?
5. Who are the major players in the global Adeno-Associated Virus (AAV) Gene Therapy market?
6. What are the growth factors driving the market demand?
btl

Table of Contents

1 Supply Summary
1.1 Adeno-Associated Virus (AAV) Gene Therapy Introduction
1.2 World Adeno-Associated Virus (AAV) Gene Therapy Market Size & Forecast (2018 & 2022 & 2029)
1.3 World Adeno-Associated Virus (AAV) Gene Therapy Total Market by Region (by Headquarter Location)
1.3.1 World Adeno-Associated Virus (AAV) Gene Therapy Market Size by Region (2018-2029), (by Headquarter Location)
1.3.2 United States Adeno-Associated Virus (AAV) Gene Therapy Market Size (2018-2029)
1.3.3 China Adeno-Associated Virus (AAV) Gene Therapy Market Size (2018-2029)
1.3.4 Europe Adeno-Associated Virus (AAV) Gene Therapy Market Size (2018-2029)
1.3.5 Japan Adeno-Associated Virus (AAV) Gene Therapy Market Size (2018-2029)
1.3.6 South Korea Adeno-Associated Virus (AAV) Gene Therapy Market Size (2018-2029)
1.3.7 ASEAN Adeno-Associated Virus (AAV) Gene Therapy Market Size (2018-2029)
1.3.8 India Adeno-Associated Virus (AAV) Gene Therapy Market Size (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Adeno-Associated Virus (AAV) Gene Therapy Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Adeno-Associated Virus (AAV) Gene Therapy Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War

2 Demand Summary
2.1 World Adeno-Associated Virus (AAV) Gene Therapy Consumption Value (2018-2029)
2.2 World Adeno-Associated Virus (AAV) Gene Therapy Consumption Value by Region
2.2.1 World Adeno-Associated Virus (AAV) Gene Therapy Consumption Value by Region (2018-2023)
2.2.2 World Adeno-Associated Virus (AAV) Gene Therapy Consumption Value Forecast by Region (2024-2029)
2.3 United States Adeno-Associated Virus (AAV) Gene Therapy Consumption Value (2018-2029)
2.4 China Adeno-Associated Virus (AAV) Gene Therapy Consumption Value (2018-2029)
2.5 Europe Adeno-Associated Virus (AAV) Gene Therapy Consumption Value (2018-2029)
2.6 Japan Adeno-Associated Virus (AAV) Gene Therapy Consumption Value (2018-2029)
2.7 South Korea Adeno-Associated Virus (AAV) Gene Therapy Consumption Value (2018-2029)
2.8 ASEAN Adeno-Associated Virus (AAV) Gene Therapy Consumption Value (2018-2029)
2.9 India Adeno-Associated Virus (AAV) Gene Therapy Consumption Value (2018-2029)

3 World Adeno-Associated Virus (AAV) Gene Therapy Companies Competitive Analysis
3.1 World Adeno-Associated Virus (AAV) Gene Therapy Revenue by Player (2018-2023)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Adeno-Associated Virus (AAV) Gene Therapy Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Adeno-Associated Virus (AAV) Gene Therapy in 2022
3.2.3 Global Concentration Ratios (CR8) for Adeno-Associated Virus (AAV) Gene Therapy in 2022
3.3 Adeno-Associated Virus (AAV) Gene Therapy Company Evaluation Quadrant
3.4 Adeno-Associated Virus (AAV) Gene Therapy Market: Overall Company Footprint Analysis
3.4.1 Adeno-Associated Virus (AAV) Gene Therapy Market: Region Footprint
3.4.2 Adeno-Associated Virus (AAV) Gene Therapy Market: Company Product Type Footprint
3.4.3 Adeno-Associated Virus (AAV) Gene Therapy Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity

4 United States VS China VS Rest of the World (by Headquarter Location)
4.1 United States VS China: Adeno-Associated Virus (AAV) Gene Therapy Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Adeno-Associated Virus (AAV) Gene Therapy Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
4.1.2 United States VS China: Adeno-Associated Virus (AAV) Gene Therapy Revenue Market Share Comparison (2018 & 2022 & 2029)
4.2 United States Based Companies VS China Based Companies: Adeno-Associated Virus (AAV) Gene Therapy Consumption Value Comparison
4.2.1 United States VS China: Adeno-Associated Virus (AAV) Gene Therapy Consumption Value Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Adeno-Associated Virus (AAV) Gene Therapy Consumption Value Market Share Comparison (2018 & 2022 & 2029)
4.3 United States Based Adeno-Associated Virus (AAV) Gene Therapy Companies and Market Share, 2018-2023
4.3.1 United States Based Adeno-Associated Virus (AAV) Gene Therapy Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Adeno-Associated Virus (AAV) Gene Therapy Revenue, (2018-2023)
4.4 China Based Companies Adeno-Associated Virus (AAV) Gene Therapy Revenue and Market Share, 2018-2023
4.4.1 China Based Adeno-Associated Virus (AAV) Gene Therapy Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Adeno-Associated Virus (AAV) Gene Therapy Revenue, (2018-2023)
4.5 Rest of World Based Adeno-Associated Virus (AAV) Gene Therapy Companies and Market Share, 2018-2023
4.5.1 Rest of World Based Adeno-Associated Virus (AAV) Gene Therapy Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies Adeno-Associated Virus (AAV) Gene Therapy Revenue, (2018-2023)

5 Market Analysis by Type
5.1 World Adeno-Associated Virus (AAV) Gene Therapy Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Luxturna
5.2.2 Zolgensma
5.2.3 Others
5.3 Market Segment by Type
5.3.1 World Adeno-Associated Virus (AAV) Gene Therapy Market Size by Type (2018-2023)
5.3.2 World Adeno-Associated Virus (AAV) Gene Therapy Market Size by Type (2024-2029)
5.3.3 World Adeno-Associated Virus (AAV) Gene Therapy Market Size Market Share by Type (2018-2029)

6 Market Analysis by Application
6.1 World Adeno-Associated Virus (AAV) Gene Therapy Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Central Nervous System Diseases
6.2.2 Ocular Diseases
6.2.3 Liver-directed Diseases
6.2.4 Other Hereditary Diseases
6.2.5 Other Hereditary Diseases
6.3 Market Segment by Application
6.3.1 World Adeno-Associated Virus (AAV) Gene Therapy Market Size by Application (2018-2023)
6.3.2 World Adeno-Associated Virus (AAV) Gene Therapy Market Size by Application (2024-2029)
6.3.3 World Adeno-Associated Virus (AAV) Gene Therapy Market Size by Application (2018-2029)

7 Company Profiles
7.1 Creative Biolabs
7.1.1 Creative Biolabs Details
7.1.2 Creative Biolabs Major Business
7.1.3 Creative Biolabs Adeno-Associated Virus (AAV) Gene Therapy Product and Services
7.1.4 Creative Biolabs Adeno-Associated Virus (AAV) Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
7.1.5 Creative Biolabs Recent Developments/Updates
7.1.6 Creative Biolabs Competitive Strengths & Weaknesses
7.2 Affinia Therapeutics
7.2.1 Affinia Therapeutics Details
7.2.2 Affinia Therapeutics Major Business
7.2.3 Affinia Therapeutics Adeno-Associated Virus (AAV) Gene Therapy Product and Services
7.2.4 Affinia Therapeutics Adeno-Associated Virus (AAV) Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
7.2.5 Affinia Therapeutics Recent Developments/Updates
7.2.6 Affinia Therapeutics Competitive Strengths & Weaknesses
7.3 Spark Therapeutics
7.3.1 Spark Therapeutics Details
7.3.2 Spark Therapeutics Major Business
7.3.3 Spark Therapeutics Adeno-Associated Virus (AAV) Gene Therapy Product and Services
7.3.4 Spark Therapeutics Adeno-Associated Virus (AAV) Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
7.3.5 Spark Therapeutics Recent Developments/Updates
7.3.6 Spark Therapeutics Competitive Strengths & Weaknesses
7.4 AGC Biologics
7.4.1 AGC Biologics Details
7.4.2 AGC Biologics Major Business
7.4.3 AGC Biologics Adeno-Associated Virus (AAV) Gene Therapy Product and Services
7.4.4 AGC Biologics Adeno-Associated Virus (AAV) Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
7.4.5 AGC Biologics Recent Developments/Updates
7.4.6 AGC Biologics Competitive Strengths & Weaknesses
7.5 StrideBio
7.5.1 StrideBio Details
7.5.2 StrideBio Major Business
7.5.3 StrideBio Adeno-Associated Virus (AAV) Gene Therapy Product and Services
7.5.4 StrideBio Adeno-Associated Virus (AAV) Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
7.5.5 StrideBio Recent Developments/Updates
7.5.6 StrideBio Competitive Strengths & Weaknesses
7.6 SIRION Biotech
7.6.1 SIRION Biotech Details
7.6.2 SIRION Biotech Major Business
7.6.3 SIRION Biotech Adeno-Associated Virus (AAV) Gene Therapy Product and Services
7.6.4 SIRION Biotech Adeno-Associated Virus (AAV) Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
7.6.5 SIRION Biotech Recent Developments/Updates
7.6.6 SIRION Biotech Competitive Strengths & Weaknesses
7.7 Neurophth Biotechnology
7.7.1 Neurophth Biotechnology Details
7.7.2 Neurophth Biotechnology Major Business
7.7.3 Neurophth Biotechnology Adeno-Associated Virus (AAV) Gene Therapy Product and Services
7.7.4 Neurophth Biotechnology Adeno-Associated Virus (AAV) Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
7.7.5 Neurophth Biotechnology Recent Developments/Updates
7.7.6 Neurophth Biotechnology Competitive Strengths & Weaknesses
7.8 Belief BioMed
7.8.1 Belief BioMed Details
7.8.2 Belief BioMed Major Business
7.8.3 Belief BioMed Adeno-Associated Virus (AAV) Gene Therapy Product and Services
7.8.4 Belief BioMed Adeno-Associated Virus (AAV) Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
7.8.5 Belief BioMed Recent Developments/Updates
7.8.6 Belief BioMed Competitive Strengths & Weaknesses
7.9 BiBo Biopharma Engineering Co., LTD.
7.9.1 BiBo Biopharma Engineering Co., LTD. Details
7.9.2 BiBo Biopharma Engineering Co., LTD. Major Business
7.9.3 BiBo Biopharma Engineering Co., LTD. Adeno-Associated Virus (AAV) Gene Therapy Product and Services
7.9.4 BiBo Biopharma Engineering Co., LTD. Adeno-Associated Virus (AAV) Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
7.9.5 BiBo Biopharma Engineering Co., LTD. Recent Developments/Updates
7.9.6 BiBo Biopharma Engineering Co., LTD. Competitive Strengths & Weaknesses
7.10 Beihai Kangcheng
7.10.1 Beihai Kangcheng Details
7.10.2 Beihai Kangcheng Major Business
7.10.3 Beihai Kangcheng Adeno-Associated Virus (AAV) Gene Therapy Product and Services
7.10.4 Beihai Kangcheng Adeno-Associated Virus (AAV) Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
7.10.5 Beihai Kangcheng Recent Developments/Updates
7.10.6 Beihai Kangcheng Competitive Strengths & Weaknesses
7.11 PackGene Biotech
7.11.1 PackGene Biotech Details
7.11.2 PackGene Biotech Major Business
7.11.3 PackGene Biotech Adeno-Associated Virus (AAV) Gene Therapy Product and Services
7.11.4 PackGene Biotech Adeno-Associated Virus (AAV) Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
7.11.5 PackGene Biotech Recent Developments/Updates
7.11.6 PackGene Biotech Competitive Strengths & Weaknesses
7.12 Sarepta Therapeutics
7.12.1 Sarepta Therapeutics Details
7.12.2 Sarepta Therapeutics Major Business
7.12.3 Sarepta Therapeutics Adeno-Associated Virus (AAV) Gene Therapy Product and Services
7.12.4 Sarepta Therapeutics Adeno-Associated Virus (AAV) Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
7.12.5 Sarepta Therapeutics Recent Developments/Updates
7.12.6 Sarepta Therapeutics Competitive Strengths & Weaknesses
7.13 Carbon BioSciences
7.13.1 Carbon BioSciences Details
7.13.2 Carbon BioSciences Major Business
7.13.3 Carbon BioSciences Adeno-Associated Virus (AAV) Gene Therapy Product and Services
7.13.4 Carbon BioSciences Adeno-Associated Virus (AAV) Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
7.13.5 Carbon BioSciences Recent Developments/Updates
7.13.6 Carbon BioSciences Competitive Strengths & Weaknesses
7.14 Kelonia Therapeutics
7.14.1 Kelonia Therapeutics Details
7.14.2 Kelonia Therapeutics Major Business
7.14.3 Kelonia Therapeutics Adeno-Associated Virus (AAV) Gene Therapy Product and Services
7.14.4 Kelonia Therapeutics Adeno-Associated Virus (AAV) Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
7.14.5 Kelonia Therapeutics Recent Developments/Updates
7.14.6 Kelonia Therapeutics Competitive Strengths & Weaknesses
7.15 Roche
7.15.1 Roche Details
7.15.2 Roche Major Business
7.15.3 Roche Adeno-Associated Virus (AAV) Gene Therapy Product and Services
7.15.4 Roche Adeno-Associated Virus (AAV) Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
7.15.5 Roche Recent Developments/Updates
7.15.6 Roche Competitive Strengths & Weaknesses
7.16 Remedium Bio
7.16.1 Remedium Bio Details
7.16.2 Remedium Bio Major Business
7.16.3 Remedium Bio Adeno-Associated Virus (AAV) Gene Therapy Product and Services
7.16.4 Remedium Bio Adeno-Associated Virus (AAV) Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
7.16.5 Remedium Bio Recent Developments/Updates
7.16.6 Remedium Bio Competitive Strengths & Weaknesses

8 Industry Chain Analysis
8.1 Adeno-Associated Virus (AAV) Gene Therapy Industry Chain
8.2 Adeno-Associated Virus (AAV) Gene Therapy Upstream Analysis
8.3 Adeno-Associated Virus (AAV) Gene Therapy Midstream Analysis
8.4 Adeno-Associated Virus (AAV) Gene Therapy Downstream Analysis

9 Research Findings and Conclusion

10 Appendix
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
btl

Table of Figures

List of Tables
Table 1. World Adeno-Associated Virus (AAV) Gene Therapy Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
Table 2. World Adeno-Associated Virus (AAV) Gene Therapy Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
Table 3. World Adeno-Associated Virus (AAV) Gene Therapy Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
Table 4. World Adeno-Associated Virus (AAV) Gene Therapy Revenue Market Share by Region (2018-2023), (by Headquarter Location)
Table 5. World Adeno-Associated Virus (AAV) Gene Therapy Revenue Market Share by Region (2024-2029), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Adeno-Associated Virus (AAV) Gene Therapy Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
Table 8. World Adeno-Associated Virus (AAV) Gene Therapy Consumption Value by Region (2018-2023) & (USD Million)
Table 9. World Adeno-Associated Virus (AAV) Gene Therapy Consumption Value Forecast by Region (2024-2029) & (USD Million)
Table 10. World Adeno-Associated Virus (AAV) Gene Therapy Revenue by Player (2018-2023) & (USD Million)
Table 11. Revenue Market Share of Key Adeno-Associated Virus (AAV) Gene Therapy Players in 2022
Table 12. World Adeno-Associated Virus (AAV) Gene Therapy Industry Rank of Major Player, Based on Revenue in 2022
Table 13. Global Adeno-Associated Virus (AAV) Gene Therapy Company Evaluation Quadrant
Table 14. Head Office of Key Adeno-Associated Virus (AAV) Gene Therapy Player
Table 15. Adeno-Associated Virus (AAV) Gene Therapy Market: Company Product Type Footprint
Table 16. Adeno-Associated Virus (AAV) Gene Therapy Market: Company Product Application Footprint
Table 17. Adeno-Associated Virus (AAV) Gene Therapy Mergers & Acquisitions Activity
Table 18. United States VS China Adeno-Associated Virus (AAV) Gene Therapy Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 19. United States VS China Adeno-Associated Virus (AAV) Gene Therapy Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 20. United States Based Adeno-Associated Virus (AAV) Gene Therapy Companies, Headquarters (States, Country)
Table 21. United States Based Companies Adeno-Associated Virus (AAV) Gene Therapy Revenue, (2018-2023) & (USD Million)
Table 22. United States Based Companies Adeno-Associated Virus (AAV) Gene Therapy Revenue Market Share (2018-2023)
Table 23. China Based Adeno-Associated Virus (AAV) Gene Therapy Companies, Headquarters (Province, Country)
Table 24. China Based Companies Adeno-Associated Virus (AAV) Gene Therapy Revenue, (2018-2023) & (USD Million)
Table 25. China Based Companies Adeno-Associated Virus (AAV) Gene Therapy Revenue Market Share (2018-2023)
Table 26. Rest of World Based Adeno-Associated Virus (AAV) Gene Therapy Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies Adeno-Associated Virus (AAV) Gene Therapy Revenue, (2018-2023) & (USD Million)
Table 28. Rest of World Based Companies Adeno-Associated Virus (AAV) Gene Therapy Revenue Market Share (2018-2023)
Table 29. World Adeno-Associated Virus (AAV) Gene Therapy Market Size by Type, (USD Million), 2018 & 2022 & 2029
Table 30. World Adeno-Associated Virus (AAV) Gene Therapy Market Size by Type (2018-2023) & (USD Million)
Table 31. World Adeno-Associated Virus (AAV) Gene Therapy Market Size by Type (2024-2029) & (USD Million)
Table 32. World Adeno-Associated Virus (AAV) Gene Therapy Market Size by Application, (USD Million), 2018 & 2022 & 2029
Table 33. World Adeno-Associated Virus (AAV) Gene Therapy Market Size by Application (2018-2023) & (USD Million)
Table 34. World Adeno-Associated Virus (AAV) Gene Therapy Market Size by Application (2024-2029) & (USD Million)
Table 35. Creative Biolabs Basic Information, Area Served and Competitors
Table 36. Creative Biolabs Major Business
Table 37. Creative Biolabs Adeno-Associated Virus (AAV) Gene Therapy Product and Services
Table 38. Creative Biolabs Adeno-Associated Virus (AAV) Gene Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 39. Creative Biolabs Recent Developments/Updates
Table 40. Creative Biolabs Competitive Strengths & Weaknesses
Table 41. Affinia Therapeutics Basic Information, Area Served and Competitors
Table 42. Affinia Therapeutics Major Business
Table 43. Affinia Therapeutics Adeno-Associated Virus (AAV) Gene Therapy Product and Services
Table 44. Affinia Therapeutics Adeno-Associated Virus (AAV) Gene Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 45. Affinia Therapeutics Recent Developments/Updates
Table 46. Affinia Therapeutics Competitive Strengths & Weaknesses
Table 47. Spark Therapeutics Basic Information, Area Served and Competitors
Table 48. Spark Therapeutics Major Business
Table 49. Spark Therapeutics Adeno-Associated Virus (AAV) Gene Therapy Product and Services
Table 50. Spark Therapeutics Adeno-Associated Virus (AAV) Gene Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 51. Spark Therapeutics Recent Developments/Updates
Table 52. Spark Therapeutics Competitive Strengths & Weaknesses
Table 53. AGC Biologics Basic Information, Area Served and Competitors
Table 54. AGC Biologics Major Business
Table 55. AGC Biologics Adeno-Associated Virus (AAV) Gene Therapy Product and Services
Table 56. AGC Biologics Adeno-Associated Virus (AAV) Gene Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 57. AGC Biologics Recent Developments/Updates
Table 58. AGC Biologics Competitive Strengths & Weaknesses
Table 59. StrideBio Basic Information, Area Served and Competitors
Table 60. StrideBio Major Business
Table 61. StrideBio Adeno-Associated Virus (AAV) Gene Therapy Product and Services
Table 62. StrideBio Adeno-Associated Virus (AAV) Gene Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 63. StrideBio Recent Developments/Updates
Table 64. StrideBio Competitive Strengths & Weaknesses
Table 65. SIRION Biotech Basic Information, Area Served and Competitors
Table 66. SIRION Biotech Major Business
Table 67. SIRION Biotech Adeno-Associated Virus (AAV) Gene Therapy Product and Services
Table 68. SIRION Biotech Adeno-Associated Virus (AAV) Gene Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 69. SIRION Biotech Recent Developments/Updates
Table 70. SIRION Biotech Competitive Strengths & Weaknesses
Table 71. Neurophth Biotechnology Basic Information, Area Served and Competitors
Table 72. Neurophth Biotechnology Major Business
Table 73. Neurophth Biotechnology Adeno-Associated Virus (AAV) Gene Therapy Product and Services
Table 74. Neurophth Biotechnology Adeno-Associated Virus (AAV) Gene Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 75. Neurophth Biotechnology Recent Developments/Updates
Table 76. Neurophth Biotechnology Competitive Strengths & Weaknesses
Table 77. Belief BioMed Basic Information, Area Served and Competitors
Table 78. Belief BioMed Major Business
Table 79. Belief BioMed Adeno-Associated Virus (AAV) Gene Therapy Product and Services
Table 80. Belief BioMed Adeno-Associated Virus (AAV) Gene Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 81. Belief BioMed Recent Developments/Updates
Table 82. Belief BioMed Competitive Strengths & Weaknesses
Table 83. BiBo Biopharma Engineering Co., LTD. Basic Information, Area Served and Competitors
Table 84. BiBo Biopharma Engineering Co., LTD. Major Business
Table 85. BiBo Biopharma Engineering Co., LTD. Adeno-Associated Virus (AAV) Gene Therapy Product and Services
Table 86. BiBo Biopharma Engineering Co., LTD. Adeno-Associated Virus (AAV) Gene Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 87. BiBo Biopharma Engineering Co., LTD. Recent Developments/Updates
Table 88. BiBo Biopharma Engineering Co., LTD. Competitive Strengths & Weaknesses
Table 89. Beihai Kangcheng Basic Information, Area Served and Competitors
Table 90. Beihai Kangcheng Major Business
Table 91. Beihai Kangcheng Adeno-Associated Virus (AAV) Gene Therapy Product and Services
Table 92. Beihai Kangcheng Adeno-Associated Virus (AAV) Gene Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 93. Beihai Kangcheng Recent Developments/Updates
Table 94. Beihai Kangcheng Competitive Strengths & Weaknesses
Table 95. PackGene Biotech Basic Information, Area Served and Competitors
Table 96. PackGene Biotech Major Business
Table 97. PackGene Biotech Adeno-Associated Virus (AAV) Gene Therapy Product and Services
Table 98. PackGene Biotech Adeno-Associated Virus (AAV) Gene Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 99. PackGene Biotech Recent Developments/Updates
Table 100. PackGene Biotech Competitive Strengths & Weaknesses
Table 101. Sarepta Therapeutics Basic Information, Area Served and Competitors
Table 102. Sarepta Therapeutics Major Business
Table 103. Sarepta Therapeutics Adeno-Associated Virus (AAV) Gene Therapy Product and Services
Table 104. Sarepta Therapeutics Adeno-Associated Virus (AAV) Gene Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 105. Sarepta Therapeutics Recent Developments/Updates
Table 106. Sarepta Therapeutics Competitive Strengths & Weaknesses
Table 107. Carbon BioSciences Basic Information, Area Served and Competitors
Table 108. Carbon BioSciences Major Business
Table 109. Carbon BioSciences Adeno-Associated Virus (AAV) Gene Therapy Product and Services
Table 110. Carbon BioSciences Adeno-Associated Virus (AAV) Gene Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 111. Carbon BioSciences Recent Developments/Updates
Table 112. Carbon BioSciences Competitive Strengths & Weaknesses
Table 113. Kelonia Therapeutics Basic Information, Area Served and Competitors
Table 114. Kelonia Therapeutics Major Business
Table 115. Kelonia Therapeutics Adeno-Associated Virus (AAV) Gene Therapy Product and Services
Table 116. Kelonia Therapeutics Adeno-Associated Virus (AAV) Gene Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 117. Kelonia Therapeutics Recent Developments/Updates
Table 118. Kelonia Therapeutics Competitive Strengths & Weaknesses
Table 119. Roche Basic Information, Area Served and Competitors
Table 120. Roche Major Business
Table 121. Roche Adeno-Associated Virus (AAV) Gene Therapy Product and Services
Table 122. Roche Adeno-Associated Virus (AAV) Gene Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 123. Roche Recent Developments/Updates
Table 124. Remedium Bio Basic Information, Area Served and Competitors
Table 125. Remedium Bio Major Business
Table 126. Remedium Bio Adeno-Associated Virus (AAV) Gene Therapy Product and Services
Table 127. Remedium Bio Adeno-Associated Virus (AAV) Gene Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 128. Global Key Players of Adeno-Associated Virus (AAV) Gene Therapy Upstream (Raw Materials)
Table 129. Adeno-Associated Virus (AAV) Gene Therapy Typical Customers
List of Figure
Figure 1. Adeno-Associated Virus (AAV) Gene Therapy Picture
Figure 2. World Adeno-Associated Virus (AAV) Gene Therapy Total Market Size: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Adeno-Associated Virus (AAV) Gene Therapy Total Market Size (2018-2029) & (USD Million)
Figure 4. World Adeno-Associated Virus (AAV) Gene Therapy Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
Figure 5. World Adeno-Associated Virus (AAV) Gene Therapy Revenue Market Share by Region (2018-2029), (by Headquarter Location)
Figure 6. United States Based Company Adeno-Associated Virus (AAV) Gene Therapy Revenue (2018-2029) & (USD Million)
Figure 7. China Based Company Adeno-Associated Virus (AAV) Gene Therapy Revenue (2018-2029) & (USD Million)
Figure 8. Europe Based Company Adeno-Associated Virus (AAV) Gene Therapy Revenue (2018-2029) & (USD Million)
Figure 9. Japan Based Company Adeno-Associated Virus (AAV) Gene Therapy Revenue (2018-2029) & (USD Million)
Figure 10. South Korea Based Company Adeno-Associated Virus (AAV) Gene Therapy Revenue (2018-2029) & (USD Million)
Figure 11. ASEAN Based Company Adeno-Associated Virus (AAV) Gene Therapy Revenue (2018-2029) & (USD Million)
Figure 12. India Based Company Adeno-Associated Virus (AAV) Gene Therapy Revenue (2018-2029) & (USD Million)
Figure 13. Adeno-Associated Virus (AAV) Gene Therapy Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Adeno-Associated Virus (AAV) Gene Therapy Consumption Value (2018-2029) & (USD Million)
Figure 16. World Adeno-Associated Virus (AAV) Gene Therapy Consumption Value Market Share by Region (2018-2029)
Figure 17. United States Adeno-Associated Virus (AAV) Gene Therapy Consumption Value (2018-2029) & (USD Million)
Figure 18. China Adeno-Associated Virus (AAV) Gene Therapy Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe Adeno-Associated Virus (AAV) Gene Therapy Consumption Value (2018-2029) & (USD Million)
Figure 20. Japan Adeno-Associated Virus (AAV) Gene Therapy Consumption Value (2018-2029) & (USD Million)
Figure 21. South Korea Adeno-Associated Virus (AAV) Gene Therapy Consumption Value (2018-2029) & (USD Million)
Figure 22. ASEAN Adeno-Associated Virus (AAV) Gene Therapy Consumption Value (2018-2029) & (USD Million)
Figure 23. India Adeno-Associated Virus (AAV) Gene Therapy Consumption Value (2018-2029) & (USD Million)
Figure 24. Producer Shipments of Adeno-Associated Virus (AAV) Gene Therapy by Player Revenue ($MM) and Market Share (%): 2022
Figure 25. Global Four-firm Concentration Ratios (CR4) for Adeno-Associated Virus (AAV) Gene Therapy Markets in 2022
Figure 26. Global Four-firm Concentration Ratios (CR8) for Adeno-Associated Virus (AAV) Gene Therapy Markets in 2022
Figure 27. United States VS China: Adeno-Associated Virus (AAV) Gene Therapy Revenue Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Adeno-Associated Virus (AAV) Gene Therapy Consumption Value Market Share Comparison (2018 & 2022 & 2029)
Figure 29. World Adeno-Associated Virus (AAV) Gene Therapy Market Size by Type, (USD Million), 2018 & 2022 & 2029
Figure 30. World Adeno-Associated Virus (AAV) Gene Therapy Market Size Market Share by Type in 2022
Figure 31. Luxturna
Figure 32. Zolgensma
Figure 33. Others
Figure 34. World Adeno-Associated Virus (AAV) Gene Therapy Market Size Market Share by Type (2018-2029)
Figure 35. World Adeno-Associated Virus (AAV) Gene Therapy Market Size by Application, (USD Million), 2018 & 2022 & 2029
Figure 36. World Adeno-Associated Virus (AAV) Gene Therapy Market Size Market Share by Application in 2022
Figure 37. Central Nervous System Diseases
Figure 38. Ocular Diseases
Figure 39. Liver-directed Diseases
Figure 40. Other Hereditary Diseases
Figure 41. Adeno-Associated Virus (AAV) Gene Therapy Industrial Chain
Figure 42. Methodology
Figure 43. Research Process and Data Source
btl

Research Methodology

Client Requirements

yuan2

Review and analyze client requirements

yuan2

Discussion of all the project requirements and queries

Flexibility Check

yuan2

Project Feasibility Analysis

yuan2

Finalizing tentative research programme

yuan2

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

yuan2

Determination of key drivers, restraints, challenge, and opportunity

yuan2

Identifies market needs and trends

Market Size Estimation & Forecast

yuan2

Estimation of historical data based on secondary and primary data

yuan2

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

yuan2

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

yuan2

Consideration of geography, region-specific product/service demand for region segments

yuan2

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

tuBiao1

Data Source

yuan2

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

yuan2

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

yuan2

Collection of data

yuan2

Cumulating and collating the essential qualitative and quantitative data

yuan2

Generation of report in client requested format by research analysts

yuan2

Reviews by expert analysts

yuan2

Final quality check

yuan2

Clarifying queries

yuan2

Receiving feedback

yuan2

Ensuring satisfaction

  • yuan01
    liuCheng01

    01 Identification of data

    This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.

  • yuan01
    liuCheng01

    02 Evaluation of Market Dynamic

    This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.

  • yuan01
    liuCheng01

    03 Collection of Data

    This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.

  • yuan01
    liuCheng01

    04 Collaboration of Data

    This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.

  • yuan01
    liuCheng01

    05 Verification and Analysis

    This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

btl

Companies Mentioned

Creative Biolabs
Affinia Therapeutics
Spark Therapeutics
AGC Biologics
StrideBio
SIRION Biotech
Neurophth Biotechnology
Belief BioMed
BiBo Biopharma Engineering Co., LTD.
Beihai Kangcheng
PackGene Biotech
Sarepta Therapeutics
Carbon BioSciences
Kelonia Therapeutics
Roche
Remedium Bio
shop_t

Purchase Options

jiaGou

Add To Cart

jiaGou

Buy Now

masterCard
visa
jcb
americanExpress
shop_b
Global Adeno-Associated Virus (AAV) Gene Therapy Supply, Demand and Key Producers, 2023-2029

Global Adeno-Associated Virus (AAV) Gene Therapy Supply, Demand and Key Producers, 2023-2029

Page: 123

Published Date: 08 Jun 2023

Category: Service & Software

PDF Download

Get FREE Sample

Customize Request

Description

arrow-d3
btl

Description

The global Adeno-Associated Virus (AAV) Gene Therapy market size is expected to reach $ 2966.6 million by 2029, rising at a market growth of 8.4% CAGR during the forecast period (2023-2029).

This report studies the global Adeno-Associated Virus (AAV) Gene Therapy demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for Adeno-Associated Virus (AAV) Gene Therapy, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Adeno-Associated Virus (AAV) Gene Therapy that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Adeno-Associated Virus (AAV) Gene Therapy total market, 2018-2029, (USD Million)
Global Adeno-Associated Virus (AAV) Gene Therapy total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Adeno-Associated Virus (AAV) Gene Therapy total market, key domestic companies and share, (USD Million)
Global Adeno-Associated Virus (AAV) Gene Therapy revenue by player and market share 2018-2023, (USD Million)
Global Adeno-Associated Virus (AAV) Gene Therapy total market by Type, CAGR, 2018-2029, (USD Million)
Global Adeno-Associated Virus (AAV) Gene Therapy total market by Application, CAGR, 2018-2029, (USD Million)
This reports profiles major players in the global Adeno-Associated Virus (AAV) Gene Therapy market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Creative Biolabs, Affinia Therapeutics, Spark Therapeutics, AGC Biologics, StrideBio, SIRION Biotech, Neurophth Biotechnology, Belief BioMed and BiBo Biopharma Engineering Co., LTD., etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Adeno-Associated Virus (AAV) Gene Therapy market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global Adeno-Associated Virus (AAV) Gene Therapy Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World

Global Adeno-Associated Virus (AAV) Gene Therapy Market, Segmentation by Type
Luxturna
Zolgensma
Others

Global Adeno-Associated Virus (AAV) Gene Therapy Market, Segmentation by Application
Central Nervous System Diseases
Ocular Diseases
Liver-directed Diseases
Other Hereditary Diseases

Companies Profiled:
Creative Biolabs
Affinia Therapeutics
Spark Therapeutics
AGC Biologics
StrideBio
SIRION Biotech
Neurophth Biotechnology
Belief BioMed
BiBo Biopharma Engineering Co., LTD.
Beihai Kangcheng
PackGene Biotech
Sarepta Therapeutics
Carbon BioSciences
Kelonia Therapeutics
Roche
Remedium Bio

Key Questions Answered
1. How big is the global Adeno-Associated Virus (AAV) Gene Therapy market?
2. What is the demand of the global Adeno-Associated Virus (AAV) Gene Therapy market?
3. What is the year over year growth of the global Adeno-Associated Virus (AAV) Gene Therapy market?
4. What is the total value of the global Adeno-Associated Virus (AAV) Gene Therapy market?
5. Who are the major players in the global Adeno-Associated Virus (AAV) Gene Therapy market?
6. What are the growth factors driving the market demand?
btl

Table of Contents

1 Supply Summary
1.1 Adeno-Associated Virus (AAV) Gene Therapy Introduction
1.2 World Adeno-Associated Virus (AAV) Gene Therapy Market Size & Forecast (2018 & 2022 & 2029)
1.3 World Adeno-Associated Virus (AAV) Gene Therapy Total Market by Region (by Headquarter Location)
1.3.1 World Adeno-Associated Virus (AAV) Gene Therapy Market Size by Region (2018-2029), (by Headquarter Location)
1.3.2 United States Adeno-Associated Virus (AAV) Gene Therapy Market Size (2018-2029)
1.3.3 China Adeno-Associated Virus (AAV) Gene Therapy Market Size (2018-2029)
1.3.4 Europe Adeno-Associated Virus (AAV) Gene Therapy Market Size (2018-2029)
1.3.5 Japan Adeno-Associated Virus (AAV) Gene Therapy Market Size (2018-2029)
1.3.6 South Korea Adeno-Associated Virus (AAV) Gene Therapy Market Size (2018-2029)
1.3.7 ASEAN Adeno-Associated Virus (AAV) Gene Therapy Market Size (2018-2029)
1.3.8 India Adeno-Associated Virus (AAV) Gene Therapy Market Size (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Adeno-Associated Virus (AAV) Gene Therapy Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Adeno-Associated Virus (AAV) Gene Therapy Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War

2 Demand Summary
2.1 World Adeno-Associated Virus (AAV) Gene Therapy Consumption Value (2018-2029)
2.2 World Adeno-Associated Virus (AAV) Gene Therapy Consumption Value by Region
2.2.1 World Adeno-Associated Virus (AAV) Gene Therapy Consumption Value by Region (2018-2023)
2.2.2 World Adeno-Associated Virus (AAV) Gene Therapy Consumption Value Forecast by Region (2024-2029)
2.3 United States Adeno-Associated Virus (AAV) Gene Therapy Consumption Value (2018-2029)
2.4 China Adeno-Associated Virus (AAV) Gene Therapy Consumption Value (2018-2029)
2.5 Europe Adeno-Associated Virus (AAV) Gene Therapy Consumption Value (2018-2029)
2.6 Japan Adeno-Associated Virus (AAV) Gene Therapy Consumption Value (2018-2029)
2.7 South Korea Adeno-Associated Virus (AAV) Gene Therapy Consumption Value (2018-2029)
2.8 ASEAN Adeno-Associated Virus (AAV) Gene Therapy Consumption Value (2018-2029)
2.9 India Adeno-Associated Virus (AAV) Gene Therapy Consumption Value (2018-2029)

3 World Adeno-Associated Virus (AAV) Gene Therapy Companies Competitive Analysis
3.1 World Adeno-Associated Virus (AAV) Gene Therapy Revenue by Player (2018-2023)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Adeno-Associated Virus (AAV) Gene Therapy Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Adeno-Associated Virus (AAV) Gene Therapy in 2022
3.2.3 Global Concentration Ratios (CR8) for Adeno-Associated Virus (AAV) Gene Therapy in 2022
3.3 Adeno-Associated Virus (AAV) Gene Therapy Company Evaluation Quadrant
3.4 Adeno-Associated Virus (AAV) Gene Therapy Market: Overall Company Footprint Analysis
3.4.1 Adeno-Associated Virus (AAV) Gene Therapy Market: Region Footprint
3.4.2 Adeno-Associated Virus (AAV) Gene Therapy Market: Company Product Type Footprint
3.4.3 Adeno-Associated Virus (AAV) Gene Therapy Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity

4 United States VS China VS Rest of the World (by Headquarter Location)
4.1 United States VS China: Adeno-Associated Virus (AAV) Gene Therapy Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Adeno-Associated Virus (AAV) Gene Therapy Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
4.1.2 United States VS China: Adeno-Associated Virus (AAV) Gene Therapy Revenue Market Share Comparison (2018 & 2022 & 2029)
4.2 United States Based Companies VS China Based Companies: Adeno-Associated Virus (AAV) Gene Therapy Consumption Value Comparison
4.2.1 United States VS China: Adeno-Associated Virus (AAV) Gene Therapy Consumption Value Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Adeno-Associated Virus (AAV) Gene Therapy Consumption Value Market Share Comparison (2018 & 2022 & 2029)
4.3 United States Based Adeno-Associated Virus (AAV) Gene Therapy Companies and Market Share, 2018-2023
4.3.1 United States Based Adeno-Associated Virus (AAV) Gene Therapy Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Adeno-Associated Virus (AAV) Gene Therapy Revenue, (2018-2023)
4.4 China Based Companies Adeno-Associated Virus (AAV) Gene Therapy Revenue and Market Share, 2018-2023
4.4.1 China Based Adeno-Associated Virus (AAV) Gene Therapy Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Adeno-Associated Virus (AAV) Gene Therapy Revenue, (2018-2023)
4.5 Rest of World Based Adeno-Associated Virus (AAV) Gene Therapy Companies and Market Share, 2018-2023
4.5.1 Rest of World Based Adeno-Associated Virus (AAV) Gene Therapy Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies Adeno-Associated Virus (AAV) Gene Therapy Revenue, (2018-2023)

5 Market Analysis by Type
5.1 World Adeno-Associated Virus (AAV) Gene Therapy Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Luxturna
5.2.2 Zolgensma
5.2.3 Others
5.3 Market Segment by Type
5.3.1 World Adeno-Associated Virus (AAV) Gene Therapy Market Size by Type (2018-2023)
5.3.2 World Adeno-Associated Virus (AAV) Gene Therapy Market Size by Type (2024-2029)
5.3.3 World Adeno-Associated Virus (AAV) Gene Therapy Market Size Market Share by Type (2018-2029)

6 Market Analysis by Application
6.1 World Adeno-Associated Virus (AAV) Gene Therapy Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Central Nervous System Diseases
6.2.2 Ocular Diseases
6.2.3 Liver-directed Diseases
6.2.4 Other Hereditary Diseases
6.2.5 Other Hereditary Diseases
6.3 Market Segment by Application
6.3.1 World Adeno-Associated Virus (AAV) Gene Therapy Market Size by Application (2018-2023)
6.3.2 World Adeno-Associated Virus (AAV) Gene Therapy Market Size by Application (2024-2029)
6.3.3 World Adeno-Associated Virus (AAV) Gene Therapy Market Size by Application (2018-2029)

7 Company Profiles
7.1 Creative Biolabs
7.1.1 Creative Biolabs Details
7.1.2 Creative Biolabs Major Business
7.1.3 Creative Biolabs Adeno-Associated Virus (AAV) Gene Therapy Product and Services
7.1.4 Creative Biolabs Adeno-Associated Virus (AAV) Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
7.1.5 Creative Biolabs Recent Developments/Updates
7.1.6 Creative Biolabs Competitive Strengths & Weaknesses
7.2 Affinia Therapeutics
7.2.1 Affinia Therapeutics Details
7.2.2 Affinia Therapeutics Major Business
7.2.3 Affinia Therapeutics Adeno-Associated Virus (AAV) Gene Therapy Product and Services
7.2.4 Affinia Therapeutics Adeno-Associated Virus (AAV) Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
7.2.5 Affinia Therapeutics Recent Developments/Updates
7.2.6 Affinia Therapeutics Competitive Strengths & Weaknesses
7.3 Spark Therapeutics
7.3.1 Spark Therapeutics Details
7.3.2 Spark Therapeutics Major Business
7.3.3 Spark Therapeutics Adeno-Associated Virus (AAV) Gene Therapy Product and Services
7.3.4 Spark Therapeutics Adeno-Associated Virus (AAV) Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
7.3.5 Spark Therapeutics Recent Developments/Updates
7.3.6 Spark Therapeutics Competitive Strengths & Weaknesses
7.4 AGC Biologics
7.4.1 AGC Biologics Details
7.4.2 AGC Biologics Major Business
7.4.3 AGC Biologics Adeno-Associated Virus (AAV) Gene Therapy Product and Services
7.4.4 AGC Biologics Adeno-Associated Virus (AAV) Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
7.4.5 AGC Biologics Recent Developments/Updates
7.4.6 AGC Biologics Competitive Strengths & Weaknesses
7.5 StrideBio
7.5.1 StrideBio Details
7.5.2 StrideBio Major Business
7.5.3 StrideBio Adeno-Associated Virus (AAV) Gene Therapy Product and Services
7.5.4 StrideBio Adeno-Associated Virus (AAV) Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
7.5.5 StrideBio Recent Developments/Updates
7.5.6 StrideBio Competitive Strengths & Weaknesses
7.6 SIRION Biotech
7.6.1 SIRION Biotech Details
7.6.2 SIRION Biotech Major Business
7.6.3 SIRION Biotech Adeno-Associated Virus (AAV) Gene Therapy Product and Services
7.6.4 SIRION Biotech Adeno-Associated Virus (AAV) Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
7.6.5 SIRION Biotech Recent Developments/Updates
7.6.6 SIRION Biotech Competitive Strengths & Weaknesses
7.7 Neurophth Biotechnology
7.7.1 Neurophth Biotechnology Details
7.7.2 Neurophth Biotechnology Major Business
7.7.3 Neurophth Biotechnology Adeno-Associated Virus (AAV) Gene Therapy Product and Services
7.7.4 Neurophth Biotechnology Adeno-Associated Virus (AAV) Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
7.7.5 Neurophth Biotechnology Recent Developments/Updates
7.7.6 Neurophth Biotechnology Competitive Strengths & Weaknesses
7.8 Belief BioMed
7.8.1 Belief BioMed Details
7.8.2 Belief BioMed Major Business
7.8.3 Belief BioMed Adeno-Associated Virus (AAV) Gene Therapy Product and Services
7.8.4 Belief BioMed Adeno-Associated Virus (AAV) Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
7.8.5 Belief BioMed Recent Developments/Updates
7.8.6 Belief BioMed Competitive Strengths & Weaknesses
7.9 BiBo Biopharma Engineering Co., LTD.
7.9.1 BiBo Biopharma Engineering Co., LTD. Details
7.9.2 BiBo Biopharma Engineering Co., LTD. Major Business
7.9.3 BiBo Biopharma Engineering Co., LTD. Adeno-Associated Virus (AAV) Gene Therapy Product and Services
7.9.4 BiBo Biopharma Engineering Co., LTD. Adeno-Associated Virus (AAV) Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
7.9.5 BiBo Biopharma Engineering Co., LTD. Recent Developments/Updates
7.9.6 BiBo Biopharma Engineering Co., LTD. Competitive Strengths & Weaknesses
7.10 Beihai Kangcheng
7.10.1 Beihai Kangcheng Details
7.10.2 Beihai Kangcheng Major Business
7.10.3 Beihai Kangcheng Adeno-Associated Virus (AAV) Gene Therapy Product and Services
7.10.4 Beihai Kangcheng Adeno-Associated Virus (AAV) Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
7.10.5 Beihai Kangcheng Recent Developments/Updates
7.10.6 Beihai Kangcheng Competitive Strengths & Weaknesses
7.11 PackGene Biotech
7.11.1 PackGene Biotech Details
7.11.2 PackGene Biotech Major Business
7.11.3 PackGene Biotech Adeno-Associated Virus (AAV) Gene Therapy Product and Services
7.11.4 PackGene Biotech Adeno-Associated Virus (AAV) Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
7.11.5 PackGene Biotech Recent Developments/Updates
7.11.6 PackGene Biotech Competitive Strengths & Weaknesses
7.12 Sarepta Therapeutics
7.12.1 Sarepta Therapeutics Details
7.12.2 Sarepta Therapeutics Major Business
7.12.3 Sarepta Therapeutics Adeno-Associated Virus (AAV) Gene Therapy Product and Services
7.12.4 Sarepta Therapeutics Adeno-Associated Virus (AAV) Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
7.12.5 Sarepta Therapeutics Recent Developments/Updates
7.12.6 Sarepta Therapeutics Competitive Strengths & Weaknesses
7.13 Carbon BioSciences
7.13.1 Carbon BioSciences Details
7.13.2 Carbon BioSciences Major Business
7.13.3 Carbon BioSciences Adeno-Associated Virus (AAV) Gene Therapy Product and Services
7.13.4 Carbon BioSciences Adeno-Associated Virus (AAV) Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
7.13.5 Carbon BioSciences Recent Developments/Updates
7.13.6 Carbon BioSciences Competitive Strengths & Weaknesses
7.14 Kelonia Therapeutics
7.14.1 Kelonia Therapeutics Details
7.14.2 Kelonia Therapeutics Major Business
7.14.3 Kelonia Therapeutics Adeno-Associated Virus (AAV) Gene Therapy Product and Services
7.14.4 Kelonia Therapeutics Adeno-Associated Virus (AAV) Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
7.14.5 Kelonia Therapeutics Recent Developments/Updates
7.14.6 Kelonia Therapeutics Competitive Strengths & Weaknesses
7.15 Roche
7.15.1 Roche Details
7.15.2 Roche Major Business
7.15.3 Roche Adeno-Associated Virus (AAV) Gene Therapy Product and Services
7.15.4 Roche Adeno-Associated Virus (AAV) Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
7.15.5 Roche Recent Developments/Updates
7.15.6 Roche Competitive Strengths & Weaknesses
7.16 Remedium Bio
7.16.1 Remedium Bio Details
7.16.2 Remedium Bio Major Business
7.16.3 Remedium Bio Adeno-Associated Virus (AAV) Gene Therapy Product and Services
7.16.4 Remedium Bio Adeno-Associated Virus (AAV) Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
7.16.5 Remedium Bio Recent Developments/Updates
7.16.6 Remedium Bio Competitive Strengths & Weaknesses

8 Industry Chain Analysis
8.1 Adeno-Associated Virus (AAV) Gene Therapy Industry Chain
8.2 Adeno-Associated Virus (AAV) Gene Therapy Upstream Analysis
8.3 Adeno-Associated Virus (AAV) Gene Therapy Midstream Analysis
8.4 Adeno-Associated Virus (AAV) Gene Therapy Downstream Analysis

9 Research Findings and Conclusion

10 Appendix
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
btl

Table of Figures

List of Tables
Table 1. World Adeno-Associated Virus (AAV) Gene Therapy Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
Table 2. World Adeno-Associated Virus (AAV) Gene Therapy Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
Table 3. World Adeno-Associated Virus (AAV) Gene Therapy Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
Table 4. World Adeno-Associated Virus (AAV) Gene Therapy Revenue Market Share by Region (2018-2023), (by Headquarter Location)
Table 5. World Adeno-Associated Virus (AAV) Gene Therapy Revenue Market Share by Region (2024-2029), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Adeno-Associated Virus (AAV) Gene Therapy Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
Table 8. World Adeno-Associated Virus (AAV) Gene Therapy Consumption Value by Region (2018-2023) & (USD Million)
Table 9. World Adeno-Associated Virus (AAV) Gene Therapy Consumption Value Forecast by Region (2024-2029) & (USD Million)
Table 10. World Adeno-Associated Virus (AAV) Gene Therapy Revenue by Player (2018-2023) & (USD Million)
Table 11. Revenue Market Share of Key Adeno-Associated Virus (AAV) Gene Therapy Players in 2022
Table 12. World Adeno-Associated Virus (AAV) Gene Therapy Industry Rank of Major Player, Based on Revenue in 2022
Table 13. Global Adeno-Associated Virus (AAV) Gene Therapy Company Evaluation Quadrant
Table 14. Head Office of Key Adeno-Associated Virus (AAV) Gene Therapy Player
Table 15. Adeno-Associated Virus (AAV) Gene Therapy Market: Company Product Type Footprint
Table 16. Adeno-Associated Virus (AAV) Gene Therapy Market: Company Product Application Footprint
Table 17. Adeno-Associated Virus (AAV) Gene Therapy Mergers & Acquisitions Activity
Table 18. United States VS China Adeno-Associated Virus (AAV) Gene Therapy Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 19. United States VS China Adeno-Associated Virus (AAV) Gene Therapy Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 20. United States Based Adeno-Associated Virus (AAV) Gene Therapy Companies, Headquarters (States, Country)
Table 21. United States Based Companies Adeno-Associated Virus (AAV) Gene Therapy Revenue, (2018-2023) & (USD Million)
Table 22. United States Based Companies Adeno-Associated Virus (AAV) Gene Therapy Revenue Market Share (2018-2023)
Table 23. China Based Adeno-Associated Virus (AAV) Gene Therapy Companies, Headquarters (Province, Country)
Table 24. China Based Companies Adeno-Associated Virus (AAV) Gene Therapy Revenue, (2018-2023) & (USD Million)
Table 25. China Based Companies Adeno-Associated Virus (AAV) Gene Therapy Revenue Market Share (2018-2023)
Table 26. Rest of World Based Adeno-Associated Virus (AAV) Gene Therapy Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies Adeno-Associated Virus (AAV) Gene Therapy Revenue, (2018-2023) & (USD Million)
Table 28. Rest of World Based Companies Adeno-Associated Virus (AAV) Gene Therapy Revenue Market Share (2018-2023)
Table 29. World Adeno-Associated Virus (AAV) Gene Therapy Market Size by Type, (USD Million), 2018 & 2022 & 2029
Table 30. World Adeno-Associated Virus (AAV) Gene Therapy Market Size by Type (2018-2023) & (USD Million)
Table 31. World Adeno-Associated Virus (AAV) Gene Therapy Market Size by Type (2024-2029) & (USD Million)
Table 32. World Adeno-Associated Virus (AAV) Gene Therapy Market Size by Application, (USD Million), 2018 & 2022 & 2029
Table 33. World Adeno-Associated Virus (AAV) Gene Therapy Market Size by Application (2018-2023) & (USD Million)
Table 34. World Adeno-Associated Virus (AAV) Gene Therapy Market Size by Application (2024-2029) & (USD Million)
Table 35. Creative Biolabs Basic Information, Area Served and Competitors
Table 36. Creative Biolabs Major Business
Table 37. Creative Biolabs Adeno-Associated Virus (AAV) Gene Therapy Product and Services
Table 38. Creative Biolabs Adeno-Associated Virus (AAV) Gene Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 39. Creative Biolabs Recent Developments/Updates
Table 40. Creative Biolabs Competitive Strengths & Weaknesses
Table 41. Affinia Therapeutics Basic Information, Area Served and Competitors
Table 42. Affinia Therapeutics Major Business
Table 43. Affinia Therapeutics Adeno-Associated Virus (AAV) Gene Therapy Product and Services
Table 44. Affinia Therapeutics Adeno-Associated Virus (AAV) Gene Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 45. Affinia Therapeutics Recent Developments/Updates
Table 46. Affinia Therapeutics Competitive Strengths & Weaknesses
Table 47. Spark Therapeutics Basic Information, Area Served and Competitors
Table 48. Spark Therapeutics Major Business
Table 49. Spark Therapeutics Adeno-Associated Virus (AAV) Gene Therapy Product and Services
Table 50. Spark Therapeutics Adeno-Associated Virus (AAV) Gene Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 51. Spark Therapeutics Recent Developments/Updates
Table 52. Spark Therapeutics Competitive Strengths & Weaknesses
Table 53. AGC Biologics Basic Information, Area Served and Competitors
Table 54. AGC Biologics Major Business
Table 55. AGC Biologics Adeno-Associated Virus (AAV) Gene Therapy Product and Services
Table 56. AGC Biologics Adeno-Associated Virus (AAV) Gene Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 57. AGC Biologics Recent Developments/Updates
Table 58. AGC Biologics Competitive Strengths & Weaknesses
Table 59. StrideBio Basic Information, Area Served and Competitors
Table 60. StrideBio Major Business
Table 61. StrideBio Adeno-Associated Virus (AAV) Gene Therapy Product and Services
Table 62. StrideBio Adeno-Associated Virus (AAV) Gene Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 63. StrideBio Recent Developments/Updates
Table 64. StrideBio Competitive Strengths & Weaknesses
Table 65. SIRION Biotech Basic Information, Area Served and Competitors
Table 66. SIRION Biotech Major Business
Table 67. SIRION Biotech Adeno-Associated Virus (AAV) Gene Therapy Product and Services
Table 68. SIRION Biotech Adeno-Associated Virus (AAV) Gene Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 69. SIRION Biotech Recent Developments/Updates
Table 70. SIRION Biotech Competitive Strengths & Weaknesses
Table 71. Neurophth Biotechnology Basic Information, Area Served and Competitors
Table 72. Neurophth Biotechnology Major Business
Table 73. Neurophth Biotechnology Adeno-Associated Virus (AAV) Gene Therapy Product and Services
Table 74. Neurophth Biotechnology Adeno-Associated Virus (AAV) Gene Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 75. Neurophth Biotechnology Recent Developments/Updates
Table 76. Neurophth Biotechnology Competitive Strengths & Weaknesses
Table 77. Belief BioMed Basic Information, Area Served and Competitors
Table 78. Belief BioMed Major Business
Table 79. Belief BioMed Adeno-Associated Virus (AAV) Gene Therapy Product and Services
Table 80. Belief BioMed Adeno-Associated Virus (AAV) Gene Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 81. Belief BioMed Recent Developments/Updates
Table 82. Belief BioMed Competitive Strengths & Weaknesses
Table 83. BiBo Biopharma Engineering Co., LTD. Basic Information, Area Served and Competitors
Table 84. BiBo Biopharma Engineering Co., LTD. Major Business
Table 85. BiBo Biopharma Engineering Co., LTD. Adeno-Associated Virus (AAV) Gene Therapy Product and Services
Table 86. BiBo Biopharma Engineering Co., LTD. Adeno-Associated Virus (AAV) Gene Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 87. BiBo Biopharma Engineering Co., LTD. Recent Developments/Updates
Table 88. BiBo Biopharma Engineering Co., LTD. Competitive Strengths & Weaknesses
Table 89. Beihai Kangcheng Basic Information, Area Served and Competitors
Table 90. Beihai Kangcheng Major Business
Table 91. Beihai Kangcheng Adeno-Associated Virus (AAV) Gene Therapy Product and Services
Table 92. Beihai Kangcheng Adeno-Associated Virus (AAV) Gene Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 93. Beihai Kangcheng Recent Developments/Updates
Table 94. Beihai Kangcheng Competitive Strengths & Weaknesses
Table 95. PackGene Biotech Basic Information, Area Served and Competitors
Table 96. PackGene Biotech Major Business
Table 97. PackGene Biotech Adeno-Associated Virus (AAV) Gene Therapy Product and Services
Table 98. PackGene Biotech Adeno-Associated Virus (AAV) Gene Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 99. PackGene Biotech Recent Developments/Updates
Table 100. PackGene Biotech Competitive Strengths & Weaknesses
Table 101. Sarepta Therapeutics Basic Information, Area Served and Competitors
Table 102. Sarepta Therapeutics Major Business
Table 103. Sarepta Therapeutics Adeno-Associated Virus (AAV) Gene Therapy Product and Services
Table 104. Sarepta Therapeutics Adeno-Associated Virus (AAV) Gene Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 105. Sarepta Therapeutics Recent Developments/Updates
Table 106. Sarepta Therapeutics Competitive Strengths & Weaknesses
Table 107. Carbon BioSciences Basic Information, Area Served and Competitors
Table 108. Carbon BioSciences Major Business
Table 109. Carbon BioSciences Adeno-Associated Virus (AAV) Gene Therapy Product and Services
Table 110. Carbon BioSciences Adeno-Associated Virus (AAV) Gene Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 111. Carbon BioSciences Recent Developments/Updates
Table 112. Carbon BioSciences Competitive Strengths & Weaknesses
Table 113. Kelonia Therapeutics Basic Information, Area Served and Competitors
Table 114. Kelonia Therapeutics Major Business
Table 115. Kelonia Therapeutics Adeno-Associated Virus (AAV) Gene Therapy Product and Services
Table 116. Kelonia Therapeutics Adeno-Associated Virus (AAV) Gene Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 117. Kelonia Therapeutics Recent Developments/Updates
Table 118. Kelonia Therapeutics Competitive Strengths & Weaknesses
Table 119. Roche Basic Information, Area Served and Competitors
Table 120. Roche Major Business
Table 121. Roche Adeno-Associated Virus (AAV) Gene Therapy Product and Services
Table 122. Roche Adeno-Associated Virus (AAV) Gene Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 123. Roche Recent Developments/Updates
Table 124. Remedium Bio Basic Information, Area Served and Competitors
Table 125. Remedium Bio Major Business
Table 126. Remedium Bio Adeno-Associated Virus (AAV) Gene Therapy Product and Services
Table 127. Remedium Bio Adeno-Associated Virus (AAV) Gene Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 128. Global Key Players of Adeno-Associated Virus (AAV) Gene Therapy Upstream (Raw Materials)
Table 129. Adeno-Associated Virus (AAV) Gene Therapy Typical Customers
List of Figure
Figure 1. Adeno-Associated Virus (AAV) Gene Therapy Picture
Figure 2. World Adeno-Associated Virus (AAV) Gene Therapy Total Market Size: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Adeno-Associated Virus (AAV) Gene Therapy Total Market Size (2018-2029) & (USD Million)
Figure 4. World Adeno-Associated Virus (AAV) Gene Therapy Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
Figure 5. World Adeno-Associated Virus (AAV) Gene Therapy Revenue Market Share by Region (2018-2029), (by Headquarter Location)
Figure 6. United States Based Company Adeno-Associated Virus (AAV) Gene Therapy Revenue (2018-2029) & (USD Million)
Figure 7. China Based Company Adeno-Associated Virus (AAV) Gene Therapy Revenue (2018-2029) & (USD Million)
Figure 8. Europe Based Company Adeno-Associated Virus (AAV) Gene Therapy Revenue (2018-2029) & (USD Million)
Figure 9. Japan Based Company Adeno-Associated Virus (AAV) Gene Therapy Revenue (2018-2029) & (USD Million)
Figure 10. South Korea Based Company Adeno-Associated Virus (AAV) Gene Therapy Revenue (2018-2029) & (USD Million)
Figure 11. ASEAN Based Company Adeno-Associated Virus (AAV) Gene Therapy Revenue (2018-2029) & (USD Million)
Figure 12. India Based Company Adeno-Associated Virus (AAV) Gene Therapy Revenue (2018-2029) & (USD Million)
Figure 13. Adeno-Associated Virus (AAV) Gene Therapy Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Adeno-Associated Virus (AAV) Gene Therapy Consumption Value (2018-2029) & (USD Million)
Figure 16. World Adeno-Associated Virus (AAV) Gene Therapy Consumption Value Market Share by Region (2018-2029)
Figure 17. United States Adeno-Associated Virus (AAV) Gene Therapy Consumption Value (2018-2029) & (USD Million)
Figure 18. China Adeno-Associated Virus (AAV) Gene Therapy Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe Adeno-Associated Virus (AAV) Gene Therapy Consumption Value (2018-2029) & (USD Million)
Figure 20. Japan Adeno-Associated Virus (AAV) Gene Therapy Consumption Value (2018-2029) & (USD Million)
Figure 21. South Korea Adeno-Associated Virus (AAV) Gene Therapy Consumption Value (2018-2029) & (USD Million)
Figure 22. ASEAN Adeno-Associated Virus (AAV) Gene Therapy Consumption Value (2018-2029) & (USD Million)
Figure 23. India Adeno-Associated Virus (AAV) Gene Therapy Consumption Value (2018-2029) & (USD Million)
Figure 24. Producer Shipments of Adeno-Associated Virus (AAV) Gene Therapy by Player Revenue ($MM) and Market Share (%): 2022
Figure 25. Global Four-firm Concentration Ratios (CR4) for Adeno-Associated Virus (AAV) Gene Therapy Markets in 2022
Figure 26. Global Four-firm Concentration Ratios (CR8) for Adeno-Associated Virus (AAV) Gene Therapy Markets in 2022
Figure 27. United States VS China: Adeno-Associated Virus (AAV) Gene Therapy Revenue Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Adeno-Associated Virus (AAV) Gene Therapy Consumption Value Market Share Comparison (2018 & 2022 & 2029)
Figure 29. World Adeno-Associated Virus (AAV) Gene Therapy Market Size by Type, (USD Million), 2018 & 2022 & 2029
Figure 30. World Adeno-Associated Virus (AAV) Gene Therapy Market Size Market Share by Type in 2022
Figure 31. Luxturna
Figure 32. Zolgensma
Figure 33. Others
Figure 34. World Adeno-Associated Virus (AAV) Gene Therapy Market Size Market Share by Type (2018-2029)
Figure 35. World Adeno-Associated Virus (AAV) Gene Therapy Market Size by Application, (USD Million), 2018 & 2022 & 2029
Figure 36. World Adeno-Associated Virus (AAV) Gene Therapy Market Size Market Share by Application in 2022
Figure 37. Central Nervous System Diseases
Figure 38. Ocular Diseases
Figure 39. Liver-directed Diseases
Figure 40. Other Hereditary Diseases
Figure 41. Adeno-Associated Virus (AAV) Gene Therapy Industrial Chain
Figure 42. Methodology
Figure 43. Research Process and Data Source
btl

Research Methodology

Client Requirements

yuan2

Review and analyze client requirements

yuan2

Discussion of all the project requirements and queries

Flexibility Check

yuan2

Project Feasibility Analysis

yuan2

Finalizing tentative research programme

yuan2

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

yuan2

Determination of key drivers, restraints, challenge, and opportunity

yuan2

Identifies market needs and trends

Market Size Estimation & Forecast

yuan2

Estimation of historical data based on secondary and primary data

yuan2

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

yuan2

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

yuan2

Consideration of geography, region-specific product/service demand for region segments

yuan2

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

tuBiao1

Data Source

yuan2

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

yuan2

Discussion of all the project requirements and queries

Validation and triangulation of secondary and primary source.

yuan2

Collection of data

yuan2

Cumulating and collating the essential qualitative and quantitative data

yuan2

Generation of report in client requested format by research analysts

yuan2

Reviews by expert analysts

yuan2

Final quality check

yuan2

Clarifying queries

yuan2

Receiving feedback

yuan2

Ensuring satisfaction

  • yuan01
    liuCheng01

    01 Identification of data

    This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.

  • yuan01
    liuCheng01

    02 Evaluation of Market Dynamic

    This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.

  • yuan01
    liuCheng01

    03 Collection of Data

    This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.

  • yuan01
    liuCheng01

    04 Collaboration of Data

    This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.

  • yuan01
    liuCheng01

    05 Verification and Analysis

    This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

btl

Companies Mentioned

Creative Biolabs
Affinia Therapeutics
Spark Therapeutics
AGC Biologics
StrideBio
SIRION Biotech
Neurophth Biotechnology
Belief BioMed
BiBo Biopharma Engineering Co., LTD.
Beihai Kangcheng
PackGene Biotech
Sarepta Therapeutics
Carbon BioSciences
Kelonia Therapeutics
Roche
Remedium Bio
jiaGou

Add To Cart

gouMai

Buy Now